CV Sciences appoints William McCorkle as director and Audit Committee chair

CV Sciences, Inc.

William McCorkle appointed to Board on Oct 21, 2022; will serve as Chair of Audit Committee.
Receives 500,000 stock options vesting 50% on Oct 21, 2023 and Oct 21, 2024.
Quarterly cash stipend of $5,000 for service on Board and committees.
No related-party transactions or arrangements with any other person in connection with appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William McCorkle

Director

CVSI · CV Sciences, Inc.

Effective: 2022-10-21
Filed: October 25, 2022, 7:59 PM ET

On October 21, 2022, the Board of Directors of CV Sciences, Inc. (the "Company") appointed William McCorkle as a director on the Company’s Board of Directors (the “Board”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William McCorkle was appointed as Director at CV Sciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

On October 21, 2022, the Board of Directors of CV Sciences, Inc. (the "Company") appointed William McCorkle as a director on the Company’s Board of Directors (the “Board”).

View on SEC.gov

CV Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001510964-22-000079

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.